You are here

  • Home
  • Archive
  • Volume 69, Issue 4
  • Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Clinical and epidemiological research
Concise report
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Authors

  1. Correspondence to Dr Nicolino Ruperto, IRCCS Istituto G Gaslini, Pediatria II – PRINTO, Largo Gaslini, 5, 16147 Genoa, EULAR Centre of Excellence in Rheumatology 2008-13, Italy; nicolaruperto{at}ospedale-gaslini.ge.it
View Full Text

Citation

Ruperto N, Lovell DJ, Cuttica R, et al
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Annals of the Rheumatic Diseases 2010;69:718-722.

Publication history

  • Accepted April 21, 2009
  • First published March 17, 2010.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions